Genetics and the general physician: insights, applications and future challenges

Area of Science:

• Genomics
• Human Genetics
• Pharmacogenomics

Background:

• Understanding human genetic variation is crucial for defining disease susceptibility and individual responses to treatments.
• Genome-wide association studies (GWAS) are key to identifying genetic loci linked to complex multifactorial diseases.
• Advances in genetic research offer insights into disease pathogenesis and potential therapeutic targets.

Purpose of the Study:

• To review the current state of genetic research in common multifactorial diseases.
• To highlight advances in identifying genetic determinants of disease susceptibility and drug response.
• To discuss the limitations and future directions in the field of human genetics and personalized medicine.

Main Methods:

• Review of scientific literature on genome-wide association studies (GWAS).
• Analysis of case studies in various diseases including Crohn's disease, coronary artery disease, and infectious diseases.
• Examination of pharmacogenomic examples, such as warfarin dosage and abacavir hypersensitivity.

Main Results:

• GWAS are successfully identifying new disease susceptibility loci, offering insights into pathogenesis.
• Genetic factors contributing to diseases like Crohn's, cardiovascular conditions, and infectious diseases are being elucidated.
• Pharmacogenomic applications are beginning to influence clinical practice, with ongoing evaluation for others.

Conclusions:

• Current genetic approaches have limitations, with significant genetic risk remaining unexplained.
• Further research is needed to understand rare variants, structural genomic variation, and epigenetic mechanisms.
• Ethical considerations are paramount as genetic knowledge advances personalized medicine.